Published in Lancet on October 24, 2009
Drug-Resistant Malaria: The Era of ACT. Curr Infect Dis Rep (2010) 1.33
The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials. J Biol Chem (2010) 1.13
Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum. Nat Commun (2014) 1.09
Isoprenoid biosynthesis inhibition disrupts Rab5 localization and food vacuolar integrity in Plasmodium falciparum. Eukaryot Cell (2012) 0.90
Plasmodium IspD (2-C-Methyl-D-erythritol 4-Phosphate Cytidyltransferase), an Essential and Druggable Antimalarial Target. ACS Infect Dis (2015) 0.85
A simple and inexpensive haemozoin-based colorimetric method to evaluate anti-malarial drug activity. Malar J (2012) 0.84
Evaluation of antimalarial resistance marker polymorphism in returned migrant workers in China. Antimicrob Agents Chemother (2014) 0.84
Phospholipid membrane-mediated hemozoin formation: the effects of physical properties and evidence of membrane surrounding hemozoin. PLoS One (2013) 0.82
Quantum dots: a new tool for anti-malarial drug assays. Malar J (2011) 0.81
Limited variation in vaccine candidate Plasmodium falciparum Merozoite Surface Protein-6 over multiple transmission seasons. Malar J (2010) 0.77
Polymorphisms of Plasmodium falciparum k13-propeller gene among migrant workers returning to Henan Province, China from Africa. BMC Infect Dis (2017) 0.75
Countries race to contain resistance to key antimalarial. Lancet (2009) 3.44
Insights from the genome of the biotrophic fungal plant pathogen Ustilago maydis. Nature (2006) 5.52
Catastrophic household expenditure for health care in a low-income society: a study from Nouna District, Burkina Faso. Bull World Health Organ (2006) 4.13
Malaria morbidity, treatment-seeking behaviour, and mortality in a cohort of young children in rural Burkina Faso. Trop Med Int Health (2003) 3.07
Community factors associated with malaria prevention by mosquito nets: an exploratory study in rural Burkina Faso. Trop Med Int Health (2002) 2.37
Severe anaemia in west African children: malaria or malnutrition? Lancet (2003) 2.31
Risk factors of infant and child mortality in rural Burkina Faso. Bull World Health Organ (2004) 2.24
Pathogenicity determinants in smut fungi revealed by genome comparison. Science (2010) 2.03
Assessment of factors associated with complete immunization coverage in children aged 12-23 months: a cross-sectional study in Nouna district, Burkina Faso. BMC Int Health Hum Rights (2009) 2.00
Compliance of young children with ITN protection in rural Burkina Faso. Malar J (2006) 1.96
Human papillomavirus vaccination in Africa. Lancet (2011) 1.96
Determinants of utilisation of maternal care services after the reduction of user fees: a case study from rural Burkina Faso. Health Policy (2010) 1.85
The effect of community-based health insurance on the utilization of modern health care services: evidence from Burkina Faso. Health Policy (2008) 1.81
Understanding enrolment in community health insurance in sub-Saharan Africa: a population-based case-control study in rural Burkina Faso. Bull World Health Organ (2006) 1.78
The effect of distance to health-care facilities on childhood mortality in rural Burkina Faso. Am J Epidemiol (2011) 1.78
Active sites of thioredoxin reductases: why selenoproteins? Proc Natl Acad Sci U S A (2003) 1.69
Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial. PLoS One (2009) 1.68
Malaria in rural Burkina Faso: local illness concepts, patterns of traditional treatment and influence on health-seeking behaviour. Malar J (2007) 1.65
Season of death and birth predict patterns of mortality in Burkina Faso. Int J Epidemiol (2005) 1.65
The Health and Demographic Surveillance System (HDSS) in Nouna, Burkina Faso, 1993-2007. Glob Health Action (2010) 1.64
The great failure of malaria control in Africa: a district perspective from Burkina Faso. PLoS Med (2007) 1.60
Risk factors for childhood mortality in sub-Saharan Africa. A comparison of data from a Demographic and Health Survey and from a Demographic Surveillance System. Acta Trop (2006) 1.46
Dithiol proteins as guardians of the intracellular redox milieu in parasites: old and new drug targets in trypanosomes and malaria-causing plasmodia. Angew Chem Int Ed Engl (2005) 1.46
In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisinins. Antimicrob Agents Chemother (2005) 1.46
Access to malaria treatment in young children of rural Burkina Faso. Malar J (2009) 1.41
Methylene blue as an antimalarial agent. Redox Rep (2003) 1.39
Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine. Malar J (2006) 1.37
Pattern of cause-specific childhood mortality in a malaria endemic area of Burkina Faso. Malar J (2006) 1.35
Effects of insecticide-treated bednets during early infancy in an African area of intense malaria transmission: a randomized controlled trial. Bull World Health Organ (2006) 1.35
Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis. J Med Virol (2006) 1.34
Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum. Infect Immun (2006) 1.32
Community health insurance in sub-Saharan Africa: what operational difficulties hamper its successful development? Trop Med Int Health (2009) 1.32
Patterns of malaria: cause-specific and all-cause mortality in a malaria-endemic area of west Africa. Am J Trop Med Hyg (2008) 1.28
Interactions of methylene blue with human disulfide reductases and their orthologues from Plasmodium falciparum. Antimicrob Agents Chemother (2007) 1.28
Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]. Malar J (2005) 1.28
High absolute bioavailability of methylene blue given as an aqueous oral formulation. Eur J Clin Pharmacol (2008) 1.27
Quality of antenatal care in rural southern Tanzania: a reality check. BMC Res Notes (2010) 1.24
Substandard anti-malarial drugs in Burkina Faso. Malar J (2008) 1.24
Glutathione--functions and metabolism in the malarial parasite Plasmodium falciparum. Biol Chem (2003) 1.23
Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso. Trop Med Int Health (2005) 1.23
Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. PLoS One (2008) 1.22
Cause of death distribution with InterVA and physician coding in a rural area of Burkina Faso. Trop Med Int Health (2012) 1.21
Assessing the health status of young AIDS and other orphans in Kampala, Uganda. Trop Med Int Health (2005) 1.20
Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria. Eur J Clin Pharmacol (2004) 1.19
Utilization of combined remote sensing techniques to detect environmental variables influencing malaria vector densities in rural West Africa. Int J Health Geogr (2012) 1.18
The association between protein-energy malnutrition, malaria morbidity and all-cause mortality in West African children. Trop Med Int Health (2003) 1.17
Diagnosis of red cell G6PD deficiency in rural Burkina Faso: comparison of a rapid fluorescent enzyme test on filter paper with polymerase chain reaction based genotyping. Br J Haematol (2005) 1.17
Step-wedge cluster-randomised community-based trials: an application to the study of the impact of community health insurance. Health Res Policy Syst (2008) 1.15
Crystal structure of the antioxidant enzyme glutathione reductase inactivated by peroxynitrite. J Biol Chem (2001) 1.14
The mechanism of high Mr thioredoxin reductase from Drosophila melanogaster. J Biol Chem (2003) 1.14
Compliance with focused antenatal care services: do health workers in rural Burkina Faso, Uganda and Tanzania perform all ANC procedures? Trop Med Int Health (2011) 1.14
Portrait of a lengthy vaccination trajectory in Burkina Faso: from cultural acceptance of vaccines to actual immunization. BMC Int Health Hum Rights (2009) 1.13
Comparative cost analysis of insecticide-treated net delivery strategies: sales supported by social marketing and free distribution through antenatal care. Health Policy Plan (2009) 1.12
The impact of targeted subsidies for facility-based delivery on access to care and equity - evidence from a population-based study in rural Burkina Faso. J Public Health Policy (2012) 1.11
Antenatal care services in rural Uganda: missed opportunities for good-quality care. Qual Health Res (2012) 1.11
Expanding insecticide-treated mosquito net coverage in Africa: tradeoffs between public and commercial strategies. Trop Med Int Health (2003) 1.10
Marked differences in the prevalence of chloroquine resistance between urban and rural communities in Burkina Faso. Acta Trop (2007) 1.09
Evaluation of the Affordable Medicines Facility--malaria. Lancet (2013) 1.08
'How to know what you need to do': a cross-country comparison of maternal health guidelines in Burkina Faso, Ghana and Tanzania. Implement Sci (2012) 1.06
A fluoro analogue of the menadione derivative 6-[2'-(3'-methyl)-1',4'-naphthoquinolyl]hexanoic acid is a suicide substrate of glutathione reductase. Crystal structure of the alkylated human enzyme. J Am Chem Soc (2006) 1.05
Using high spatial resolution remote sensing for risk mapping of malaria occurrence in the Nouna district, Burkina Faso. Glob Health Action (2009) 1.04
Declining malaria parasite prevalence and trends of asymptomatic parasitaemia in a seasonal transmission setting in North-Western Burkina Faso between 2000 and 2009-2012. Malar J (2013) 1.03
Comparison of all-cause and malaria-specific mortality from two West African countries with different malaria transmission patterns. Malar J (2008) 1.00
Exploring the effects of task shifting for HIV through a systems thinking lens: the case of Burkina Faso. BMC Public Health (2013) 1.00
Clinical efficacy of chloroquine in young children with uncomplicated falciparum malaria--a community-based study in rural Burkina Faso. Trop Med Int Health (2003) 1.00
X-ray structure of glutathione S-transferase from the malarial parasite Plasmodium falciparum. Proc Natl Acad Sci U S A (2003) 1.00
5-substituted tetrazoles as bioisosteres of carboxylic acids. Bioisosterism and mechanistic studies on glutathione reductase inhibitors as antimalarials. J Med Chem (2004) 1.00
Glutathione reductase-catalyzed cascade of redox reactions to bioactivate potent antimalarial 1,4-naphthoquinones--a new strategy to combat malarial parasites. J Am Chem Soc (2011) 0.98
Does enrollment status in community-based insurance lead to poorer quality of care? Evidence from Burkina Faso. Int J Equity Health (2013) 0.98
Thioredoxin reductase from the malaria mosquito Anopheles gambiae. Eur J Biochem (2003) 0.98
Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso. Acta Trop (2010) 0.98
Decreasing childhood mortality and increasing proportion of malaria deaths in rural Burkina Faso. Glob Health Action (2009) 0.98
Econometric analysis to evaluate the effect of community-based health insurance on reducing informal self-care in Burkina Faso. Health Policy Plan (2011) 0.96
Comparative structural analysis of oxidized and reduced thioredoxin from Drosophila melanogaster. J Mol Biol (2004) 0.94